Home > Healthcare > Medical Devices > Surgical Devices > Embolic Protection Devices Market

Embolic Protection Devices Market Trends

Report ID: GMI2417
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Embolic Protection Devices Market Trends

Technological improvements and breakthroughs in embolic protection devices are expected to boost the business outlook over the next ten years. Distal occlusion devices, distal filter devices, and proximal occlusion/flow-reversal devices, among other innovations, are intended to avoid embolic debris during endovascular operations. For instance, Medtronic's Mo. Ma Ultra proximal cerebral protection device uses a double-occlusion balloon system to guarantee proximal embolic protection before passing a carotid lesion. Furthermore, continuous R&D targeted at enhancing the efficacy, safety, and ease of use of these devices will contribute to their increased acceptance.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Embolic protection devices market was valued at USD 1.4 billion in 2022 and is poised to exhibit over 8.5% CAGR from 2023 to 2032 owing to the rising prevalence of cardiovascular diseases (CVDs) globally.

The embolic protection devices market from the distal filters segment is estimated to grow at above 8.5% CAGR over 2023-2032 and is expected to generate USD 1.9 billion by 2032 driven by the availability of a wide range of specifications and the surging usage of distal filters.

North America amassed over 35.5% share of the embolic protection devices market in 2022 and is foreseen to be valued at USD 1 billion by 2032 attributed to the rising prevalence of cardiovascular and neurovascular diseases in the region.

Some of the top players engaged in the industry are Transverse Medical, Inc., Abbott Laboratories, Cardinal Health, Allium Medica, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Contego Medical, LLC, Keystone Heart, Medtronic, Metactive Medical, Boston Scientific Corporation, and Innovative Cardiovascular Solutions, LLC.